e $0.3M that supported University of Hong Kong researchers in the development of a RT-
PCR test to detect SARSCoV2 from human samples. The group has now shared the tests
and relevant reagents with over 30 labs globally to enable diagnosis of COVID-19.

e $0.1M vaccine candidate development at NIAID Intramural Labs

 

Martin

From: Johnson, Martin S. (NIH/NIAID) [E]
Sent: Friday, February 14, 2020 3:56 PM
To: Fauci, Anthony (NIH/NIAID) [E]E 0 (6)>; Auchincloss, Hugh (NIH/NIAID) [E]
>; NIAID OCGR Leg <NIAIDOCGRLeg @mail.nih.gov>; McGowan, John J.

cr (1 ()

(NIK/NIAID) (E>; Harper, Jill (NIH/NIAID) [€] Ce
Crum, Wayne (NIH/NIAID) [E]fE >

Ce: Eisinger, Robert (NIH/NIAID) [E) 0) (6); Folkers, Greg (NIH/NIAID) [E]
CC >; Conrad, Patricia (NIH/NIAID) [E] (>; Marston,
Hilary (NIH/NIAID) 7] CS Lerner, Andrea (NIH/NIAID) a
CC) 6F>; Gilles, Sharon (NIH/NIAID) [E] b) (6)
Subject: FY 2020 - COVID-19 - Actual and Forecasted Spending as of 2/13/20

 

Dr. Fauci,
Attached is a narrative we are updating weekly for NIAID’s COVID-19 response.

The accompanying spreadsheet summarizes the figures and includes a summary of our
supplemental request.

We’ll provide an update by Thursday of next week.

Martin
